This infographic explores a contemporary strategy to decrease the risk of cardiovascular disease and mortality associated with end-stage kidney disease (ESKD). In haemodialysis patients, these outcomes are often linked to the interaction between malnutrition and inflammation. Improving cardiovascular outcomes for patients with ESKD requires an understanding of the mechanisms of inflammation and malnutrition and the role of pro-inflammatory uraemic toxins.
EMJ Nephrology 10 [Infographic 3] . 2022
November 2022
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given